Estimated to be 250 billion won in CFD outstanding bonds in eight stocks of 'stock price manipulation'

Reporter Kim Jisun / approved : 2023-06-09 03:00:18
  • -
  • +
  • 인쇄
 

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] It is estimated that the amount of CFD bonds in eight stocks related to the lower limit from Societe Generale Securities is estimated to reach KRW 250 billion.

According to data submitted by the Financial Supervisory Service to Lee Yong-woo of the Democratic Party of Korea, a member of the National Assembly's National Policy Committee on the 8th, the size of CFD outstanding bonds of 12 securities firms, including Kyobo, Kiwoom and Samsung Securities, totaled 252.1 billion won as of the 4th of last month. There are eight stocks involved in the lower limit situation, including Samchully (), Seoul Gas (017390), Sunkwang (003100), Daesung Holdings (016710), Sebang (004360), Dow Data (032190), Daol Investment & Securities (030210) and Harim Holdings (003380).

A total of six securities firms have failed to pay CFD bonds worth more than 10 billion won, the survey showed. The amount of securities firms with the largest number of CFD unpaid bonds was estimated at 68.5 billion won, while the amount of securities firms with the lowest amount was estimated at 860 million won. One in 13 securities firms that provide CFD did not have outstanding bonds.

CFD is an over-the-counter derivative that is considered the primer of recent large-scale stock price manipulation cases. The financial investment industry estimates that the recent controversial stock price manipulation scandal may have resulted from opposition sales due to a lack of collateral in CFD accounts. The Financial Services Commission is also currently investigating about 4,600 CFD accounts held by 18 domestic and foreign securities firms.

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Coupang Tops Online Platform Disputes Over Past Five Years, Data Shows2026.02.16
Court Acquits LG Heiress Gu Yeon-kyung and Husband in Insider Trading Case, Sparking Backlash2026.02.14
Daewoong Pharmaceutical Terminates KRW 384.5 Billion China Supply Deal for Fexuprazan2026.02.13
LG Electronics to Cancel Treasury Shares to Enhance Shareholder Value2026.02.13
Court Sides with Former ADOR CEO Min Hee-jin in First Trial Against HYBE2026.02.13
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사